ADP-ribosylation factor-dependent phospholipase D activation by VPAC receptors and a PAC(1) receptor splice variant.
暂无分享,去创建一个
[1] M. Johnson,et al. Mechanisms of phospholipase C activation by the vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide type 2 receptor. , 2001, Endocrinology.
[2] E. Lutz,et al. Printed in U.S.A. Copyright © 2000 by The Endocrine Society Gonadotropin-Releasing Hormone Receptor Activation , 2000 .
[3] M. Johnson,et al. Domains determining agonist selectivity in chimaeric VIP2 (VPAC2)/PACAP (PAC1) receptors , 1999, British journal of pharmacology.
[4] P. A. Friedman,et al. Cell-specific signaling and structure-activity relations of parathyroid hormone analogs in mouse kidney cells. , 1999, Endocrinology.
[5] M. Grossmann,et al. G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[6] D. Galson,et al. Phospholipase D- and protein kinase C isoenzyme-dependent signal transduction pathways activated by the calcitonin receptor. , 1998, Endocrinology.
[7] S. Sealfon,et al. Rhodopsin-family receptors associate with small G proteins to activate phospholipase D , 1998, Nature.
[8] M. Brann,et al. Structure/function relationships of a G-protein coupling pocket formed by the third intracellular loop of the m5 muscarinic receptor. , 1998, Biochemistry.
[9] C. Delporte,et al. The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins. , 1997, Biochimica et biophysica acta.
[10] J. Exton. New Developments in Phospholipase D* , 1997, The Journal of Biological Chemistry.
[11] D. Donnelly. The arrangement of the transmembrane helices in the secretin receptor family of G‐protein‐coupled receptors , 1997, FEBS letters.
[12] J. Wess. G‐protein‐coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G‐protein recognition , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] A. Harmar,et al. Phospholipase C Activation by VIP1 and VIP2 Receptors Expressed in COS 7 Cells Involves a Pertussis Toxin‐Sensitive Mechanism , 1996, Annals of the New York Academy of Sciences.
[14] J. Bockaert,et al. Alternative Splicing in the N-terminal Extracellular Domain of the Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Receptor Modulates Receptor Selectivity and Relative Potencies of PACAP-27 and PACAP-38 in Phospholipase C Activation* , 1996, The Journal of Biological Chemistry.
[15] R. Neubig,et al. Structural requirements for G(o) activation by receptor-derived peptides: activation and modulation domains of the alpha 2-adrenergic receptor i3c region. , 1996, Molecular pharmacology.
[16] S. Wank,et al. Cloning and Characterization of the Signal Transduction of Four Splice Variants of the Human Pituitary Adenylate Cyclase Activating Polypeptide Receptor , 1996, The Journal of Biological Chemistry.
[17] S. Rawlings,et al. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs. , 1995, Endocrinology.
[18] E. Borrelli,et al. Alternative Splicing of the Dopamine D2 Receptor Directs Specificity of Coupling to G-proteins (*) , 1995, The Journal of Biological Chemistry.
[19] S. Shioda,et al. Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Its Receptors: Neuroendocrine and Endocrine Interaction , 1995, Frontiers in Neuroendocrinology.
[20] R. Nissenson,et al. The Cytoplasmic Tail of the G-protein-coupled Receptor for Parathyroid Hormone and Parathyroid Hormone-related Protein Contains Positive and Negative Signals for Endocytosis (*) , 1995, The Journal of Biological Chemistry.
[21] M. Gershengorn,et al. Inhibition of inositol phosphate second messenger formation by intracellular loop one of a human calcitonin receptor. Expression and mutational analysis of synthetic receptor genes. , 1994, The Journal of biological chemistry.
[22] L. Slice,et al. The conserved NPXnY motif present in the gastrin-releasing peptide receptor is not a general sequestration sequence. , 1994, The Journal of biological chemistry.
[23] T. Harmar,et al. Multiple receptors for PACAP and VIP. , 1994, Trends in pharmacological sciences.
[24] C. McArdle,et al. Effects of pituitary adenylate cyclase-activating polypeptide in the pituitary: activation of two signal transduction pathways in the gonadotrope-derived alpha T3-1 cell line. , 1994, Endocrinology.
[25] S. Goldring,et al. Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family , 1993, Trends in Endocrinology & Metabolism.
[26] G. Fink,et al. The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide , 1993, FEBS letters.
[27] J. Christophe,et al. Cloning of a splice variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptor. , 1993, Biochemical and biophysical research communications.
[28] Laurent Journot,et al. Differential signal transduction by five splice variants of the PACAP receptor , 1993, Nature.
[29] G. Fink,et al. Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP) , 1993, FEBS letters.
[30] R. Shigemoto,et al. Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide , 1993, Neuron.
[31] A. Arimura,et al. Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP). , 1993, Biochemical and biophysical research communications.
[32] S. Wank,et al. Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[33] I. Nishimoto,et al. Amino acids 356–372 constitute a Gi‐activator sequence of the α2‐adrenergic receptor and have a Phe substitute in the G protein‐activator sequence motif , 1992, FEBS letters.
[34] I. Nishimoto,et al. Detection of G protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure. , 1992, The Journal of biological chemistry.
[35] R. Shigemoto,et al. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide , 1992, Neuron.
[36] Y. Sun,et al. The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. , 1992, The Journal of biological chemistry.
[37] S. Swillens. How to estimate the total receptor concentration when the specific radioactivity of the ligand is unknown. , 1992, Trends in pharmacological sciences.
[38] W. C. Probst,et al. Sequence alignment of the G-protein coupled receptor superfamily. , 1992, DNA and cell biology.
[39] R. Pittner,et al. Activation of membrane protein kinase C by glucagon and Ca(2+)-mobilizing hormones in cultured rat hepatocytes. Role of phosphatidylinositol and phosphatidylcholine hydrolysis. , 1991, The Biochemical journal.
[40] G. Fink,et al. Solubilization of a large molecular weight form of the rat LHRH receptor. , 1987, The Journal of endocrinology.